Andrew G. Robinson
76 Stuart St
Kingston, ON, Canada
Kingston, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications
Balancing Innovation and Safety: Prediction, Prevention, and Management of Pneumonitis in Lung Cancer Patients Receiving Novel Anti-Cancer Agents.
Journal: Cancers
Published: June 11, 2025
Impact of Tumor Response and Response Duration on Survival Among Participants Receiving Pembrolizumab Plus Chemotherapy as First-Line Therapy for Non-Small-Cell Lung Cancer.
Journal: Oncology and therapy
Published: March 25, 2025
Factors Influencing the Timeliness and Completeness of Appropriate Staging Investigations for Patients with Stage I-III Lung Cancer in Southeastern Ontario.
Journal: Current oncology (Toronto, Ont.)
Published: August 15, 2024
Health care system factors associated with receipt of treatment and treatment intent in stage III non-small cell lung cancer: A population-based study in Ontario.
Journal: Clinical and translational radiation oncology
Published: June 04, 2024
Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy.
Journal: Radiation oncology (London, England)
Published: April 14, 2024
Patients' considerations of time toxicity when assessing cancer treatments with marginal benefit.
Journal: The oncologist
Published: April 13, 2024
A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master Protocol.
Journal: Clinical lung cancer
Published: April 09, 2024
Trajectories of Health Care Contact Days for Patients With Stage IV Non-Small Cell Lung Cancer.
Journal: JAMA network open
Published: April 08, 2024
Brief Report: Real-World Eligibility for Clinical Trials in Patients With Extensive-Stage SCLC at a Tertiary Care Center.
Journal: JTO clinical and research reports
Published: January 23, 2024
Blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer: KEYNOTE-782.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 27, 2023
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.2.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 11, 2023
Last Updated: 09/26/2026